Literature DB >> 19803834

The levonorgestrel intrauterine system: long-term contraception and therapeutic effects.

Regine Sitruk-Ware1, Pirjo Inki.   

Abstract

The levonorgestrel intrauterine system (Mirena((R))) has been developed as a long-acting method of contraception. This medicated device, inserted into the uterus, delivers a small daily dose of a progestin, levonorgestrel, into the uterine cavity. It is one of the most effective methods of contraception and is approved in more than 100 countries for 5 years of use.

Entities:  

Year:  2005        PMID： 19803834     DOI： 10.2217/17455057.1.2.171

Source DB:  PubMed          Journal:  Womens Health (Lond)        ISSN： 1745-5057


  6 in total

1.  Effect of crosslinking on the physicochemical properties of polydimethylsiloxane-based levonorgestrel intrauterine systems.

Authors:  Suraj Fanse; Quanying Bao; Yuan Zou; Yan Wang; Diane J Burgess
Journal:  Int J Pharm       Date:  2021-10-16       Impact factor: 6.510

2.  The Effectiveness of Levonorgestrel-Releasing Intrauterine System in the Treatment of Heavy Menstrual Bleeding.

Authors:  Georgy Joy Eralil
Journal:  J Obstet Gynaecol India       Date:  2016-03-30

3.  Stromal fibroblasts from perimenopausal endometrium exhibit a different transcriptome than those from the premenopausal endometrium.

Authors:  David W Erikson; Fatima Barragan; Terhi T Piltonen; Joseph C Chen; Shaina Balayan; Juan C Irwin; Linda C Giudice
Journal:  Biol Reprod       Date:  2017-09-01       Impact factor: 4.285

4.  Levonorgestrel intrauterine system: Current role in management of heavy menstrual bleeding.

Authors:  Navneet Magon; Monica Chauhan; Poonam Goel; Sonia Malik; Krishan Kapur; Alka Kriplani; Lakhbir Dhaliwal; Suchitra N Pandit
Journal:  J Midlife Health       Date:  2013-01

5.  Comparison of levonorgestrel-releasing intrauterine device with oral progestins in heavy menstrual bleeding (HMB) cases with uterine leiomyoma (LNG-IUD and oral progestin usage in myoma uteri).

Authors:  Ayse Kavasoglu Tosun; Ismet Tosun; Necdet Suer
Journal:  Pak J Med Sci       Date:  2014-07       Impact factor: 1.088

6.  Levonorgestrel-releasing IUD versus copper IUD in control of dysmenorrhea, satisfaction and quality of life in women using IUD.

Authors:  Fatemeh Ramazanzadeh; Toktam Tavakolianfar; Mamak Shariat; Seyed Javad Purafzali Firuzabadi; Fedieh Hagholahi
Journal:  Iran J Reprod Med       Date:  2012-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.